Sunrun Inc.·4

Feb 12, 5:21 PM ET

Fenster Edward Harris 4

4 · Sunrun Inc. · Filed Feb 12, 2026

Research Summary

AI-generated summary of this filing

Updated

Sunrun (RUN) Director Edward Fenster Exercises Options, Sells Shares

What Happened
Director Edward H. Fenster exercised 250,600 stock options (exercise price $5.08) on Feb 11, 2026, paying $1,273,048. He then sold a total of 163,844 shares in open-market transactions for aggregate proceeds of about $3,269,222 (two weighted-average sale groups). He also gifted 25,000 shares the same day. The filing shows the option conversion/derivative was recorded and the option was fully vested with a Feb 11, 2026 expiration.

Key Details

  • Date of transactions: February 11, 2026.
  • Option exercise: 250,600 shares exercised at $5.08 per share = $1,273,048 cash paid.
  • Open-market sales: 134,813 shares at a weighted avg $19.79 (range $19.30–$20.29) = $2,667,801; 29,031 shares at a weighted avg $20.72 (range $20.30–$21.12) = $601,421. Total sale proceeds ≈ $3,269,222.
  • Gift: 25,000 shares were transferred as a gift (no proceeds).
  • Shares/sources: Footnote states some shares sold were to cover the exercise price and tax withholding (i.e., sale to cover costs).
  • Plan/authorization: Transactions were effected under a Rule 10b5-1 trading plan adopted Sept 3, 2025.
  • Holdings note: Shares held following the reported transactions include 3,184 restricted stock units subject to forfeiture.
  • Option details: The option was fully vested and had a 10‑year term, expiring Feb 11, 2026.

Context

  • This was an option exercise followed by immediate open‑market sales — the filer’s disclosures (footnote) indicate the sales were executed to cover the exercise price and tax obligations, which is common after option exercises and is different from discretionary selling for portfolio reasons.
  • The 25,000-share gift is not a market-driven sale and does not necessarily indicate buy/sell sentiment.
  • The trades were made under a pre-established 10b5‑1 plan, which typically schedules trades in advance and helps separate timing from inside information.

All figures are from the Form 4 filing (Accession: 0001628280-26-007798) covering transactions reported for Feb 11, 2026.

Insider Transaction Report

Form 4
Period: 2026-02-11
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-11$5.08/sh+250,600$1,273,0481,742,739 total
  • Sale

    Common Stock

    [F1][F2][F3]
    2026-02-11$19.79/sh134,813$2,667,8011,607,926 total
  • Sale

    Common Stock

    [F1][F2][F4]
    2026-02-11$20.72/sh29,031$601,4211,578,895 total
  • Gift

    Common Stock

    [F1][F5]
    2026-02-1125,0001,553,895 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    [F1][F6]
    2026-02-11250,6000 total
    Exercise: $5.08Exp: 2026-02-11Common Stock (250,600 underlying)
Footnotes (6)
  • [F1]The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on September 3, 2025.
  • [F2]Shares sold only to cover exercise price and tax obligation upon the exercise of a stock option.
  • [F3]Price represents the weighted average sale price of the shares sold. The sale price ranged from $19.30 to $20.29 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  • [F4]Price represents the weighted average sale price of the shares sold. The sale price ranged from $20.30 to $21.12 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  • [F5]Shares held following the reported transactions include 3,184 restricted stock units, which are subject to forfeiture until they vest.
  • [F6]The shares subject to the option are fully vested and exercisable. The option had a 10-year exercise period with an expiration date of February 11, 2026.
Signature
/s/ Jeanna Steele, Attorney-in-Fact|2026-02-12

Documents

1 file
  • 4
    wk-form4_1770934914.xmlPrimary

    FORM 4